Cargando…
Antiviral Resistance in Influenza Viruses: Clinical and Epidemiological Aspects
There are three classes of antiviral drugs approved for the treatment of influenza: the M2 ion channel inhibitors (amantadine, rimantadine), neuraminidase (NA) inhibitors (laninamivir, oseltamivir, peramivir, zanamivir), and the protease inhibitor (favipiravir); some of the agents are only available...
Autores principales: | van der Vries, Erhard, Ison, Michael G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122614/ http://dx.doi.org/10.1007/978-3-319-47266-9_23 |
Ejemplares similares
-
Antiviral Resistance in Influenza Viruses: Clinical and Epidemiological Aspects
por: Hayden, Frederick G.
Publicado: (2009) -
Influenza A/H3N2 virus infection in immunocompromised ferrets and emergence of antiviral resistance
por: Roosenhoff, Rueshandra, et al.
Publicado: (2018) -
Prolonged Influenza Virus Shedding and Emergence of Antiviral Resistance in Immunocompromised Patients and Ferrets
por: van der Vries, Erhard, et al.
Publicado: (2013) -
Antiviral Agents Against Respiratory Viruses
por: Ison, Michael G., et al.
Publicado: (2017) -
Influenza viruses – antiviral therapy and resistance
por: Duwe, Susanne
Publicado: (2017)